On November 30, 2015, the sixth subject received their first experimental treatment in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. This subject …
As of October 29, 2015, two subjects out of 18 have completed all treatments in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. Five participants …
On September 21, 2015 the fifth subject received their first experimental session in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. Led by Principal …
On September 1, 2015, subject five was enrolled in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. Led by Principal Investigator Phil Wolfson, M.D., …
On July 2 and July 6, 2015, the first two subjects were treated in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. The fourth subject was enrolled …
On May 29, June 1, and June 8, 2015, the first three subjects were enrolled in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. Led by Principal Investigator …
On April 9-10, 2015, the formal study initiation visits took place for our new study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. MAPS and site staff reviewed the …
On March 13, 2015, the U.S. Drug Enforcement Administration approved the Schedule I license for Phil Wolfson, M.D., the Principal Investigator for our upcoming study of MDMA-assisted psychotherapy for …
On December 15, 2014, the Research Advisory Panel of California (RAP-C) approved the protocol and informed consent documents for our upcoming study of MDMA-assisted psychotherapy for anxiety associated …
On November 13, 2014, the U.S. Food and Drug Administration approved the protocol for our upcoming study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. This randomized, …
On October 7, 2014, the protocol for our new study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness was submitted to the U.S. Food and Drug Administration for review. …
On August 6, 2014, the protocol for our new study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness was submitted to the Institutional Review Board. This randomized, …
